A 3- to 5-day Clinical Trial of Levamisole in Loiasis Infected Subjects

Summary

The aim of the study is to evaluate the safety and efficacy of a 3- and 5-day course of levamisole (2.5 mg/kg) in management of loiasis microfilaremia.

Timeline

Start

2024-06-21

Primary completion

2024-09-18

Completion

2026-02-01

Publications

• Chesnais CB, Hemilembolo MC, Sahm BA, Toutin F, Djeutassong E, Nga-Elomo N, Cuer B, Ntsiba-N'Goulou MA, Pakat M, Pion SDS, Missamou F, Boussinesq M, Campillo JT. Safety and efficacy of 3- and 5-day regimens of levamisole in loiasis: a randomized, placebo-controlled, double-blind clinical trial. Nat Commun. 2025 Jul 4;16(1):6191. doi: 10.1038/s41467-025-61479-6.

Drugs

Indications